1 / 14

Cancer or Tumor Profiling Market

Increasing demand for tumor profiling and diagnosis and therapy techniques is driven by oncologists. Increased use of biomarkers in tumor profiling and increasing use of next-generation cancer profiling sequencing methods are some of the main factors driving the growth of the tumor profiling market. Tumor profiling is used to evaluate the metabolism, properties, and mutations of the tumor that can assist discover effective therapies. Drugs that target these mutated kinases can be discovered and developed based on genetic modification. The profiling is considered a requirement to increase the s

Ronald15
Download Presentation

Cancer or Tumor Profiling Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer/Tumor Profiling Market Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15%

  2. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% “As per Polaris Market Research report, Cancer/Tumor Profiling Market is attending major innovations & transformations and is projected to reach $15.32 Billion By 2027 | CAGR: 7.15% during the conjecture period 2021 to 2028.” The global Cancer/Tumor Profiling Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Cancer/Tumor Profiling Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Cancer/Tumor Profiling Market Report Scope: The global Cancer/Tumor Profiling Market is segmented ByTechnology, By Cancer Type, By Biomarker Type, By Application, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Cancer/Tumor Profiling Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Cancer/Tumor Profiling Market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% By Technology By Cancer Type By Biomarker Type By Application By Region Type •Immunoassay •Breast •Genomic •Personalized •North America (U.S., •NGS •Lung Biomarkers Medicine Canada) •Protein Biomarkers •Others •Diagnostics •Europe •PCR •Colorectal (Germany, UK, •Prognostics France, Italy, Spain, •In Situ Hybridization •Prostate Netherlands) •Biomarker •Microarray •Melanoma •Asia Pacific (India, Japan, Discovery •Mass Spectrometry •Others China, South Korea) •Research •Others •Latin America (Brazil, Mexico, Colombia •MEA (Saudi Arabia, south Africa, Israel, UAE) ➢COVID-19 Impact Analysis for Cancer/Tumor Profiling Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Cancer/Tumor Profiling Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Cancer/Tumor Profiling Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Cancer/Tumor Profiling Market Analysis: https://www.polarismarketresearch.com/industry-analysis/cancer-tumor-profiling-market ➢Competitive Landscape - 3 -

  4. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Cancer/Tumor Profiling Market include Abott Molecular, Agendia, Boreal Genomics Inc, BD Biosciences, Caris Life Sciences, F. Hoffmann-La Roche Ltd, Foundation Medicine, Genscript Biotech Corporation, Guardant Health, Inc., Helomics Corporation, Histogene X, Hologic, Inc., HTG Molecular Diagnostics, Inc., Illumina, Inc., Nanostring Technologies, Inc., Neogenomics, Inc., Omniseq, Perthera, Qiagen N.V., Ribomed Biotechnologies, Inc., Roche Molecular Systems Inc., Sysmex Corporation and Tempus Labs https://www.polarismarketresearch.com/industry-analysis/cancer-tumor-profiling- Request for sample: market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-aways 1.5.Stakeholders 2.Executive Summary 2.1.Market Definition 2.2.Market Segmentation 3.Cancer/tumor Profiling Market Insights 3.1.Cancer/tumor Profiling– Industry snapshot 3.2.Cancer/tumor Profiling market dynamics 3.2.1.Cancer/tumor Profiling– Market Forces 3.2.1.1. Cancer/tumor Profiling Market driver analysis 3.2.1.2. Cancer/tumor Profiling Market restraint/challenges analysis 3.2.1.3. Cancer/tumor Profiling Market opportunity analysis 3.3.Industry analysis - Porter's five force 3.3.1.Bargaining power of supplier 3.3.2.Bargaining power of buyer 3.3.3.Threat of substitute 3.3.4.Threat of new entrant 3.3.5.Degree of competition 3.4.Cancer/tumor Profiling market PEST analysis - 4 -

  5. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 3.5.Value Chain Analysis 3.6.Competitive Ranking Analysis, 2019 4.Cancer/tumor Profiling Market Size and Forecast by Transducer Frequency Range 4.1.Global Cancer/tumor Profiling market share by technology, 2019 & 2027 4.2.Immunoassay 4.2.1.Global Immunoassay market estimates and forecasts, 2016 - 2027 (USD Million) 4.2.2.Global Immunoassay market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.3.Next Generation Sequencing (NGS) 4.3.1.Global NGS market estimates and forecasts, 2016 - 2027 (USD Million) 4.3.2.Global NGS market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.4.Polymerase Chain Reaction (PCR) 4.4.1.Global PCR market estimates and forecasts, 2016 - 2027 (USD Million) 4.4.2.Global PCR market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.5.In Situ Hybridization 4.5.1.Global In Situ Hybridization market estimates and forecasts, 2016 - 2027 (USD Million) 4.5.2.Global In Situ Hybridization market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.6.Microarray 4.6.1.Global Microarray market estimates and forecasts, 2016 - 2027 (USD Million) 4.6.2.Global Microarray market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.7.Mass Spectrometry 4.7.1.Global Mass Spectrometry market estimates and forecasts, 2016 - 2027 (USD Million) 4.7.2.Global Mass Spectrometry market estimates and forecasts, by region, 2016 - 2027 (USD Million) 4.8.Other Technology 4.8.1.Global Other Technology market estimates and forecasts, 2016 - 2027 (USD Million) 4.8.2.Global Other Technology market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.Cancer/tumor Profiling Market Size and Forecast by Cancer Type 5.1.Global Cancer/tumor Profiling market share by cancer type, 2019 & 2027 5.2.Breast Cancer 5.2.1.Global breast cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.2.2.Global breast cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.3.Lung Cancer 5.3.1.Global lung cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.3.2.Global lung cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.4.Colorectal Cancer 5.4.1.Global colorectal cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.4.2.Global colorectal cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) - 5 -

  6. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 5.5.Prostate Cancer 5.5.1.Global prostate cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.5.2.Global prostate cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.6.Melanoma Cancer 5.6.1.Global Melanoma cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.6.2.Global melanoma cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 5.7.Other Cancer 5.7.1.Global other cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 5.7.2.Global other cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.Cancer/tumor Profiling Market Size and Forecast by Biomarker Type 6.1.Global Cancer/tumor Profiling market share by biomarker type, 2019 & 2027 6.2.Genomic Biomarkers 6.2.1.Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.2.2.Global genomic biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.3.Protein Biomarkers 6.3.1.Global protein biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.3.2.Global protein biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 6.4.Other Biomarkers 6.4.1.Global other biomarkers cancer/tumor profiling market estimates and forecasts, 2016 - 2027 (USD Million) 6.4.2.Global other biomarkers cancer/tumor profiling market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.Cancer/tumor Profiling Market Size and Forecast by Application 7.1.Global Cancer/tumor Profiling market share by application, 2019 & 2027 7.2.Diagnostics 7.2.1.Global Cancer/tumor Profiling market from diagnostics estimates and forecasts, 2016 - 2027 (USD Million) 7.2.2.Global Cancer/tumor Profiling from diagnostics market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.3.Prognostics 7.3.1.Global Cancer/tumor Profiling market from Prognostics estimates and forecasts, 2016 - 2027 (USD Million) 7.3.2.Global hard Cancer/tumor Profiling from Prognostics market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.4.Personalized Medicine 7.4.1.Global Cancer/tumor Profiling market from Personalized Medicine estimates and forecasts, 2016 - 2027 (USD Million) 7.4.2.Global hard Cancer/tumor Profiling from Personalized Medicine market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.5.Biomarker Discovery - 6 -

  7. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 7.5.1.Global Cancer/tumor Profiling market from Biomarker Discovery estimates and forecasts, 2016 - 2027 (USD Million) 7.5.2.Global hard Cancer/tumor Profiling from Biomarker Discovery market estimates and forecasts, by region, 2016 - 2027 (USD Million) 7.6.Research 7.6.1.Global Cancer/tumor Profiling market from Research estimates and forecasts, 2016 - 2027 (USD Million) 7.6.2.Global hard Cancer/tumor Profiling from Research market estimates and forecasts, by region, 2016 - 2027 (USD Million) 8.Cancer/tumor Profiling Market Size and Forecast by Region 8.1.Global cancer/tumor profiling market share by region, 2019 & 2027 8.2.North America 8.2.1.North America cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.2.North America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.3.North America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.2.4.North America cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.2.5.U.S. 8.2.5.1. U.S. cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.5.2. U.S. cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.5.3. U.S. cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.2.5.4. U.S. cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.2.6.Canada 8.2.6.1. Canada cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.2.6.2. Canada cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.2.6.3. Canada cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.2.6.4. Canada cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.Europe 8.3.1.Europe cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.2.Europe cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.3.Europe cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.4.Europe cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.5.Germany 8.3.5.1. Germany cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.5.2. Germany cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 - 7 -

  8. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 8.3.5.3. Germany cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.5.4. Germany cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.6.UK 8.3.6.1. UK cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.6.2. UK cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.6.3. UK cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.6.4. UK cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.7.France 8.3.7.1. France cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.7.2. France cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.7.3. France cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.7.4. France cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.8.Italy 8.3.8.1. Ital cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.8.2. Italy cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.8.3. Italy cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.8.4. Italy cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.3.9.Spain 8.3.9.1. Spain cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.9.2. Spain cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.9.3. Spain cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.9.4. Spain cancer/tumor profiling market by application (USD Million), 2016 – 2027 8.3.10.Netherlands 8.3.10.1.Netherlands cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.3.10.2.Netherlands cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.3.10.3.Netherlands cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.3.10.4.Netherlands cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.Asia Pacific - 8 -

  9. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 8.4.1.Asia Pacific cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.2.Asia Pacific cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.3.Asia Pacific cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.4.Asia Pacific cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.5.China 8.4.5.1. China cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.5.2. China cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.5.3. China cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.5.4. China cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.6.South Korea 8.4.6.1. South Korea cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.6.2. South Korea cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.6.3. South Korea cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.6.4. South Korea cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.7.Japan 8.4.7.1. Japan cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.7.2. Japan cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.7.3. Japan cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.7.4. Japan cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.4.8.India 8.4.8.1. India cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.4.8.2. India cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.4.8.3. India cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.4.8.4. India cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.Latin America 8.5.1.Latin America cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.2.Latin America cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 - 9 -

  10. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 8.5.3.Latin America cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.4.Latin America cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.5.Brazil 8.5.5.1. Brazil cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.5.2. Brazil cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.5.3. Brazil cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.5.4. Brazil cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.6.Mexico 8.5.6.1. Mexico cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.6.2. Mexico cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.6.3. Mexico cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.6.4. Mexico cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.5.7.Colombia 8.5.7.1. Colombia cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.5.7.2. Colombia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.5.7.3. Colombia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.5.7.4. Colombia cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.Middle East & Africa 8.6.1.MEA cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.2.MEA cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.3.MEA cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.4.MEA cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.5.Saudi Arabia 8.6.5.1. Saudi Arabia cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.5.2. Saudi Arabia cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.5.3. Saudi Arabia cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.5.4. Saudi Arabia cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.6.South Africa 8.6.6.1. South Africa cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.6.2. South Africa cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 - 10 -

  11. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 8.6.6.3. South Africa cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.6.4. South Africa cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.7.Israel 8.6.7.1. Israel cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.7.2. Israel cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.7.3. Israel cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.7.4. Israel cancer/tumor profiling market by application (USD Million), 2016 - 2027 8.6.8.UAE 8.6.8.1. UAE cancer/tumor profiling market by technology (USD Million), 2016 - 2027 8.6.8.2. UAE cancer/tumor profiling market by cancer type (USD Million), 2016 - 2027 8.6.8.3. UAE cancer/tumor profiling market by biomarker type (USD Million), 2016 - 2027 8.6.8.4. UAE cancer/tumor profiling market by application (USD Million), 2016 - 2027 9.Company Profiles 9.1.Abott Molecular 9.1.1.Overview 9.1.2.Financials 9.1.3.Product Benchmarking 9.1.4.Recent Developments 9.2.Agendia 9.2.1.Overview 9.2.2.Financials 9.2.3.Product Benchmarking 9.2.4.Recent Developments 9.3.Boreal Genomics Inc 9.3.1.Overview 9.3.2.Financials 9.3.3.Product Benchmarking 9.3.4.Recent Developments 9.4.BD Biosciences 9.4.1.Overview 9.4.2.Financials 9.4.3.Product Benchmarking 9.4.4.Recent Developments 9.5.Caris Life Sciences 9.5.1.Overview 9.5.2.Financials 9.5.3.Product Benchmarking 9.5.4.Recent Developments 9.6.F. Hoffmann-La Roche Ltd 9.6.1.Overview - 11 -

  12. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 9.6.2.Financials 9.6.3.Product Benchmarking 9.6.4.Recent Developments 9.7.Foundation Medicine 9.7.1.Overview 9.7.2.Financials 9.7.3.Product Benchmarking 9.7.4.Recent Developments 9.8.Genscript Biotech Corporation 9.8.1.Overview 9.8.2.Financials 9.8.3.Product Benchmarking 9.8.4.Recent Developments 9.9.Guardant Health, Inc. 9.9.1.Overview 9.9.2.Financials 9.9.3.Product Benchmarking 9.9.4.Recent Developments 9.10. Helomics Corporation 9.10.1.Overview 9.10.2.Financials 9.10.3.Product Benchmarking 9.10.4.Recent Developments 9.11. Histogene X 9.11.1.Overview 9.11.2.Financials 9.11.3.Product Benchmarking 9.11.4.Recent Developments 9.12. Hologic, Inc. 9.12.1.Overview 9.12.2.Financials 9.12.3.Product Benchmarking 9.12.4.Recent Developments 9.13. HTG Molecular Diagnostics, Inc. 9.13.1.Overview 9.13.2.Financials 9.13.3.Product Benchmarking 9.13.4.Recent Developments 9.14. Illumina, Inc. 9.14.1.Overview 9.14.2.Financials 9.14.3.Product Benchmarking 9.14.4.Recent Developments 9.15. Nanostring Technologies, Inc. 9.15.1.Overview 9.15.2.Financials 9.15.3.Product Benchmarking 9.15.4.Recent Developments 9.16. Neogenomics, Inc. 9.16.1.Overview - 12 -

  13. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% 9.16.2.Financials 9.16.3.Product Benchmarking 9.16.4.Recent Developments 9.17. Omniseq 9.17.1.Overview 9.17.2.Financials 9.17.3.Product Benchmarking 9.17.4.Recent Developments 9.18. Perthera 9.18.1.Overview 9.18.2.Financials 9.18.3.Product Benchmarking 9.18.4.Recent Developments 9.19. Qiagen N.V. 9.19.1.Overview 9.19.2.Financials 9.19.3.Product Benchmarking 9.19.4.Recent Developments 9.20. Ribomed Biotechnologies, Inc. 9.20.1.Overview 9.20.2.Financials 9.20.3.Product Benchmarking 9.20.4.Recent Developments 9.21. Roche Molecular Systems Inc. 9.21.1.Overview 9.21.2.Financials 9.21.3.Product Benchmarking 9.21.4.Recent Developments 9.22. Sysmex Corporation 9.22.1.Overview 9.22.2.Financials 9.22.3.Product Benchmarking 9.22.4.Recent Developments 9.23. Tempus Labs 9.23.1.Overview 9.23.2.Financials 9.23.3.Product Benchmarking 9.23.4.Recent Developments ➢Access Press Release on Cancer/Tumor Profiling Market: https://www.polarismarketresearch.com/press-releases/cancer-tumor-profiling-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the - 13 -

  14. Cancer/Tumor Profiling Market Size Worth $15.32 Billion By 2027 | CAGR: 7.15% industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 14 -

More Related